caBIG in Action Here is a hypothetical case study that uses caBIG tools and databases: Here is a hypothetical case study that uses caBIG tools and databases:--> In the cancer glioblastoma multiforma (GBM), does expression of key genes predict disease outcome? How might these genes interact in biological networks that would influence therapeutic targeting? var FO = { movie:"http://www.the-scientist.com/supplementary/flash/54511/64.swf", width:"550", height:"500", majorver
In the cancer glioblastoma multiforma (GBM), does expression of key genes predict disease outcome? How might these genes interact in biological networks that would influence therapeutic targeting?
Please download the Adobe Flash Player to view this content:
Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.
View this Issue
In this webinar, Andre Mueller will introduce you to Honeybun, the viscometer/rheometer that will get you all the viscosity data you need.
Learn how improving sampling, standardization, and calibration streamlines quality control processes.
In this webinar, Benoit Derrien will discuss new strategies using enzymatically synthesized DNA for gene construction.
- Partnership with specialist life science distributor establishes sales channel in high-demand market and strengthens global network - Hypothermic preservation technology eliminates costs and inefficiencies of cold-chain logistics to enhance biomedical research and cell therapy development
Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Singleron Biotechnologies and Hamilton Bonaduz AG today announced the official launch of Tensor under their strategic partnership.
Zymo Research is proud to introduce the RNome Disruptive Research Grant, that is designed to empower scientists mapping the RNome and advance our overallunderstanding of RNA.
